Han, Jing
Jiangsu Normal University
3 papers on CoChatORCID 0000-0001-5605-1868
Most cited papers
- Verified
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A.-N. A., et al. (2018) · Nature Medicine
Cancer, Hypoxia, and MetabolismMitochondrial Function and Pathology
Cited by 928
- Verified
A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes
Zhao, S., Yan, Z., Du, Y., Li, Z., Tang, C., Jing, L., Sun, L., Yang, Q., Tang, X., Yuan, Y., et al. (2022) · British Journal of Pharmacology
Diabetes Treatment and ManagementRegulation of Appetite and Obesity
Cited by 30
- Verified
An updated patent review of GLP-1 receptor agonists (2020-present)
Lu, W., Zhou, Z., Jiang, N., & Han, J. (2023) · Expert Opinion on Therapeutic Patents
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free